Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,830.00
+70.00 (0.72%)
Feb 5, 2026, 3:30 PM KST

Tdspharm Revenue

Tdspharm had revenue of 8.08B KRW in the quarter ending September 30, 2025, with 25.01% growth. This brings the company's revenue in the last twelve months to 24.56B, down -20.27% year-over-year. In the year 2024, Tdspharm had annual revenue of 27.52B, down -8.42%.

Revenue (ttm)
24.56B
Revenue Growth
-20.27%
P/S Ratio
2.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
53.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202427.52B-2.53B-8.42%
Dec 31, 202330.05B4.46B17.43%
Dec 31, 202225.59B5.77B29.11%
Dec 31, 202119.82B1.80B9.97%
Dec 31, 202018.02B-1.19B-6.19%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4.56T
Celltrion3.90T
ALTEOGEN202.18B
MYUNGMOON Pharm co.,Ltd193.64B
ABL Bio88.44B
BCWORLD PHARM.77.04B
ORIENT BIO59.09B
METACARE CO.28.10B
Revenue Rankings